Livia Melro, Rafael Lessa, Marcelo Pereira Romano, Mieko Cláudia Miura, Priscilla Alves Barreto, Alexandre Sanches Laranjeira, Ana Luiza Mezzaroba, Marina Bahl, Marlus Muri Thompson, Andrea Allegrini Padial, Rodrigo Thot Leite, Gustavo Araújo, Mário Guimarães, Emerson Boschi, Eduardo Pacheco, Juliana Carvalho Ferreira, Bruno Tomazzini, Cassio Zandonai, Cíntia Loss Sartori Bustamante, Meton Soares de Alencar Filho, Vicente Cés de Souza Dantas, Eliana Caser, Priscilla Aquino, Fábio Lacerda, Gustavo Ospina-Táscon, Fabricio Jocundo Calado Freires, Mauro Esteves Hernandes, Conrado Roberto Hoffmann Filho, Glauco Adrieno Westphal, Cintia Grion, Rodrigo Biondi, Ligia Nasi Laranjeira, Israel Silva Maia, Flávia Ribeiro Machado, Lucas Petri Damiani, Alexandre Biasi Cavalcanti, Fernando Godinho Zampieri, Felipe Dal-Pizzol, Lucas Tramujas, Erica Regina Ribeiro Sady, Rodrigo Figueiredo, Ana Carolina Starke, Viviane Cordeiro Veiga, Júlia Souza Oliveira, Letícia Galvão Barbante, Marina Lazzari Nicola, Rodrigo Magalhães Gurgel, Karina Leal Negrelli, Tamiris Abait Miranda, Ruthy Perotto Fernandes, Mariangela Pimentel Pincelli, Luiz Fernando Norbin
Journal: British journal of anaesthesia 2025;134(3):693-702
PMID: 39592365
BACKGROUND
This study aimed to assess whether a driving pressure-limiting strategy based on positive end-expiratory pressure (PEEP) titration according to best respiratory system compliance and tidal volume adjustment increases the number of ventilator-free days within 28 days in patients with moderate to severe acute respiratory distress syndrome (ARDS).
METHODS
This is a multi-centre, randomised trial, enrolling adults with moderate to severe ARDS secondary to community-acquired pneumonia. Patients were randomised to a driving pressure-limiting strategy or low PEEP strategy based on a PEEP:FiO table. All patients received volume assist-control mode until day 3 or when considered ready for spontaneous modes of ventilation. The primary outcome was ventilator-free days within 28 days. Secondary outcomes were in-hospital and intensive care unit mortality at 90 days.
RESULTS
The trial was stopped because of recruitment fatigue after 214 patients were randomised. In total, 198 patients (n=96 intervention group, n=102 control group) were available for analysis (median age 63 yr, [interquartile range 47-73 yr]; 36% were women). The mean difference in driving pressure up to day 3 between the intervention and control groups was -0.7 cm HO (95% confidence interval -1.4 to -0.1 cm HO). Mean ventilator-free days were 6 (sd 9) in the driving pressure-limiting strategy group and 7 (9) in the control group (proportional odds ratio 0.72, 95% confidence interval 0.39-1.32; P=0.28). There were no significant differences regarding secondary outcomes.
CONCLUSIONS
In patients with moderate to severe ARDS secondary to community-acquired pneumonia, a driving pressure-limiting strategy did not increase the number of ventilator-free days compared with a standard low PEEP strategy within 28 days.
CLINICAL TRIAL REGISTRATION
NCT04972318.
Copyright © 2024 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.